Centhaquine
- Generic Name
- Centhaquine
- Drug Type
- Small Molecule
- Chemical Formula
- C22H25N3
- CAS Number
- 57961-90-7
- Unique Ingredient Identifier
- QD4VI0J9T5
- Background
Centhaquine is under investigation in clinical trial NCT04045327 (Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock).
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT05956418
- Locations
- 🇮🇳
KG Hospital, Coimbatore, Tamil Nadu, India
🇮🇳Aman Hospital, Vadodara, Gujarat, India
🇮🇳Dayanand Medical College & Hospital (DMCH), Ludhiāna, Punjab, India
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Phase 3
Not yet recruiting
- Conditions
- Hypovolemic Shock
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 430
- Registration Number
- NCT05251181
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS
Phase 2
Not yet recruiting
- Conditions
- COVID-19 Acute Respiratory Distress Syndrome
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2022-02-15
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05241067
PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Phase 2
Completed
- Conditions
- Blood LossHypovolemic Shock
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT04056065
- Locations
- 🇮🇳
KLE's Dr. Prabhakar Kore Hospital & Medical Research Centre, Belgaum, India
🇮🇳Dayanand Medical College & Hospital, Ludhiana, India
🇮🇳ORIANA Hospital, Varanasi, India
Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
Phase 3
Completed
- Conditions
- Hypovolemic Shock
- Interventions
- Drug: Normal saline + Standard Treatment
- First Posted Date
- 2019-08-05
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT04045327
- Locations
- 🇮🇳
Seven Star Hospital, Nagpur, Maha, India
🇮🇳Radiant Superspeciality Hospital, Amravati, India
🇮🇳ACSR Government Medical College & Hospital, Nellore, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath